Methyl 3-carbamoylbenzoate
CAS: 106748-24-7
Ref. 3D-GEA74824
| 1g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 25g | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued | ||
| 2500mg | Discontinued |
Product Information
- Methyl 3-Carbamoylbenzoate
Methyl 3-carbamoylbenzoate is a matrix metalloproteinase inhibitor that inhibits the activity of matrix metalloproteinases, a group of enzymes that are involved in the degradation of extracellular matrix proteins. Methyl 3-carbamoylbenzoate has been shown to be an effective inhibitor of Alzheimer's disease and other neurodegenerative diseases. It also has a protective effect on heart cells against infarction, which is due to its ability to inhibit restenosis. This drug also has an inhibitory effect on age-related macular degeneration (AMD). AMD is an eye disease characterized by retinal damage and loss of central vision that can lead to blindness. AMD is caused by the accumulation of lipofuscin in the eye and may be treated with drugs that inhibit or delay its formation. Methyl 3-carbamoylbenzoate has been shown to prevent lipid peroxidation, which is one step in the
